Skip to Content Skip to Search
Science, technology and culture gif

Investors

Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

GSK publishes Prospectus and Circular

We have published the Prospectus and Circular for the proposed demerger of our Consumer Healthcare business to form Haleon.

Read the press release

Access the documents

Latest information

2022 First quarter results announcement

We announced our Q1 2022 results for the period which ended 31 March 2022 on Wednesday 27 April.

Find out more

Sign up for announcements

Sign up to receive email notifications when we publish a stock exchange announcement.